EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Superior Drug Delivery Performance of Multifunctional Bilosomes: Innovative Strategy to Kill Skin Cancer Cells for Nanomedicine Application

Ewelina Waglewska iD, Julita Kulbacka iD, Urszula Bazylinska

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s450181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Ewelina Waglewska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical and Quantum Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland. Hauptthemen laut MEDLINE: Skin Neoplasms, Melanoma, Photochemotherapy, Photosensitizing Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Numerous failures in melanoma treatment as a highly aggressive form of skin cancer with an unfavorable prognosis and excessive resistance to conventional therapies are prompting an urgent search for more effective therapeutic tools. Consequently, to increase the treatment efficiency and to reduce the side effects of traditional administration ways, herein, it has become crucial to combine photodynamic therapy as a promising therapeutic approach with the selectivity and biocompatibility of a novel colloidal transdermal nanoplatform for effective delivery of hybrid cargo with synergistic effects on melanoma cells.

Methods

The self-assembled bilosomes, co-stabilized with L-α-phosphatidylcholine, sodium cholate, Pluronic® P123, and cholesterol, were designated, and the stability of colloidal vesicles was studied using dynamic and electrophoretic light scattering, also provided in cell culture medium (Dulbecco's Modified Eagle's Medium). The hybrid compounds - a classical photosensitizer (Methylene Blue) along with a complementary natural polyphenolic agent (curcumin), were successfully co-loaded, as confirmed by UV-Vis, ATR-FTIR, and fluorescent spectroscopies. The biocompatibility and usefulness of the polymer functionalized bilosome with loaded double cargo were demonstrated in vitro cyto- and phototoxicity experiments using normal keratinocytes and melanoma cancer cells.

Results

The in vitro bioimaging and immunofluorescence study upon human skin epithelial (A375) and malignant (Me45) melanoma cell lines established the protective effect of the PEGylated bilosome surface. This effect was confirmed in cytotoxicity experiments, also determined on human cutaneous (HaCaT) keratinocytes. The flow cytometry experiments indicated the enhanced uptake of the encapsulated hybrid cargo compared to the non-loaded MB and CUR molecules, as well as a selectivity of the obtained nanocarriers upon tumor cell lines. The phyto-photodynamic action provided 24h-post irradiation revealed a more significant influence of the nanoplatform on Me45 cells in contrast to the A375 cell line, causing the cell viability rate below 20% of the control.

Conclusion

As a result, we established an innovative and effective strategy for potential metastatic melanoma treatment through the synergism of phyto-photodynamic therapy and novel bilosomal-origin nanophotosensitizers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsMelanomaPhotochemotherapyPhotosensitizing AgentsCurcuminNanomedicineHumansCell Line, TumorCell SurvivalLiposomesCholesterolPhosphatidylcholinesSodium CholateDrug Delivery SystemsPoloxalene

Stichwörter der Autor:innen

A375 cellsMe45 cellsantitumor activityhuman melanomananovesicular carriersphyto-photodynamic therapy

Substanzen

Photosensitizing AgentsCurcuminLiposomesCholesterolPhosphatidylcholinesSodium CholatePoloxalene

Autor:innen und Institutionen

  • Department of Physical and Quantum Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.
  • Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Wroclaw, Poland.
  • State Research Institute Centre for Innovative Medicine, Department of Immunology and Bioelectrochemistry, Vilnius, Lithuania.

ORCID-Profile: Ewelina Waglewska, Julita Kulbacka

Zitieren

APA

Waglewska, E., Kulbacka, J., & Bazylinska, U. (2024). Superior Drug Delivery Performance of Multifunctional Bilosomes: Innovative Strategy to Kill Skin Cancer Cells for Nanomedicine Application. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s450181

Vancouver

Waglewska E, Kulbacka J, Bazylinska U. Superior Drug Delivery Performance of Multifunctional Bilosomes: Innovative Strategy to Kill Skin Cancer Cells for Nanomedicine Application. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s450181

BibTeX
@article{Waglewska2024,
  author = {Waglewska, Ewelina and Kulbacka, Julita and Bazylinska, Urszula},
  title = {Superior Drug Delivery Performance of Multifunctional Bilosomes: Innovative Strategy to Kill Skin Cancer Cells for Nanomedicine Application},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s450181}
}
Kostenlos starten →